Combinations are the Future in FLT3-Mutated AML

EP. 11: BCL2 Inhibitor Combinations in FLT3-Mutated AML

May 5th 2021

A discussion on the use of venetoclax combinations with FLT3 inhibitors, especially in older patients with FLT3-mutated acute myeloid leukemia.

EP. 12: Emerging Combinations for FLT3-Mutated AML

May 5th 2021

Jessica K. Altman, MD, and Naval G. Daver, MD, review novel combinations under investigation for the treatment of FLT3-mutated acute myeloid leukemia.